Income StatementBalance SheetCash FlowSegments
PLY

Polaryx Therapeutics, Inc. Balance Sheet Statement

Assets, liabilities, and shareholders' equity

Polaryx Therapeutics, Inc. holds $3.5M in total assets. Cash and equivalents total $3.1M. The current ratio is 3.45.

Total Assets$3.5MTotal Stockholders Equity$2.5MCash And Equivalents$3.1MTotal Current Assets$3.5MTotal Current Liabilities$1.0M
Market Cap$161.4M

Current Liabilities

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Accounts payable—-$17.0K$470.0K$850.0K
Accrued Manufacturing Costs——$21.0K$21.0K
Other Commercial Liabilities——$23.0K$45.0K
Accrued Liabilities, Current——$23.0K$45.0K
Compensation and benefits——$21.0K$21.0K
Total current liabilities——$605.0K$1.0M

Equity

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Additional paid-in capital——$104.2M$104.7M
Common stock; $0.001 par value; 6,000 shares authorized; 3,755 and 3,751 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively——$5.0K$5.0K
Retained earnings——-$99.6M-$102.2M
Total liabilities and stockholders' equity——$5.2M$3.5M
Total stockholders' equity$4.7M$4.3M$4.6M$2.5M

Current Assets

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Cash and cash equivalents—$250.0K$5.1M$3.1M
Other current assets——$27.0K$33.0K
Total current assets——$5.2M$3.5M

Non-Current Liabilities

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Accrued expenses and other liabilities——$21.0K$21.0K
Total liabilities——$605.0K$1.0M

Other

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Cash and cash equivalents, end of period462100000.0%416200000.0%514300000.0%308000000.0%
Common stock, par value (in dollars per share)——$0.00$0.00
Common stock, shares authorized (in shares)——$560.0M$560.0M
Common stock, shares issued (in shares)——$47.3M$47.3M
Common Stock, Shares, Outstanding——47.3M47.3M
Cost not yet recognized———$7.6M
Preferred Stock, Par or Stated Value Per Share——$0.00$0.00
Preferred Stock, Shares Authorized——$40.0M$40.0M
Preferred Stock, Shares Issued——$0.0$0.0
Preferred Stock, Shares Outstanding——00
Prepaid expenses———$389.0K
Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number$2.7M—$4.2M$4.2M
Working Capital———$2.5M

Non-Current Assets

MetricQ4 '24Q1 '25Q4 '25Q1 '26
Total assets——$5.2M$3.5M